{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:34:23Z","timestamp":1793284463584,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12185-026-04255-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:37:03Z","timestamp":1784659023000},"page":"640-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors associated with high probability of pulmonary hypertension in patients with myeloproliferative neoplasms"],"prefix":"10.1007","volume":"124","author":[{"given":"Orly","family":"Leiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Soo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia C.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Kahla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen","family":"Murtaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olatoyosi","family":"Odenike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"DeCara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Hyunju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"How","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"4255_CR1","doi-asserted-by":"crossref","unstructured":"Leiva O, Liu O, Kanelidis A, Swat S, Gozdecki L, Belkin M, et al. Beyond thrombosis: pulmonary hypertension and heart failure in patients with myeloproliferative neoplasms: JACC: cardiooncology state-of-the-art review. JACC CardioOncol. 2025.","DOI":"10.1016\/j.jaccao.2025.05.010"},{"issue":"2","key":"4255_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jaccao.2022.04.002","volume":"4","author":"O Leiva","year":"2022","unstructured":"Leiva O, Hobbs G, Ravid K, Libby P. Cardiovascular disease in myeloproliferative neoplasms: JACC: cardiooncology state-of-the-art review. JACC CardioOncol. 2022;4(2):166\u201382.","journal-title":"JACC CardioOncol"},{"issue":"3","key":"4255_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/ejh.13197","volume":"102","author":"M Brabrand","year":"2019","unstructured":"Brabrand M, Hansen KN, Laursen CB, Larsen TS, Vestergaard H, Abildgaard N. Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms. Eur J Haematol. 2019;102(3):227\u201334.","journal-title":"Eur J Haematol"},{"issue":"2","key":"4255_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5045\/br.2020.2020001","volume":"55","author":"MW Lee","year":"2020","unstructured":"Lee MW, Ryu H, Choi YS, Song IC, Lee HJ, Yun HJ, et al. Pulmonary hypertension in patients with Philadelphia-negative myeloproliferative neoplasms: a single-center retrospective analysis of 225 patients. Blood Res. 2020;55(2):77\u201384.","journal-title":"Blood Res"},{"key":"4255_CR5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.287497","author":"O Leiva","year":"2025","unstructured":"Leiva O, Soo S, Liu O, Smilowitz NR, Reynolds H, Shah B, et al. Characterization and prognostic implication of pulmonary hypertension among patients with myeloproliferative neoplasms. Haematologica. 2025. https:\/\/doi.org\/10.3324\/haematol.2025.287497.","journal-title":"Haematologica"},{"issue":"6","key":"4255_CR6","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1182\/bloodadvances.2024013970","volume":"9","author":"AJ Gazda","year":"2025","unstructured":"Gazda AJ, Pan D, Erdos K, Abu-Zeinah G, Racanelli A, Horn EM, et al. High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera. Blood Adv. 2025;9(6):1320\u20139.","journal-title":"Blood Adv"},{"key":"4255_CR7","volume":"0","author":"O Leiva","year":"2025","unstructured":"Leiva O, Soo S, Smilowitz NR, Reynolds H, Shah B, Bernard S, et al. Impact of echocardiographic probability of pulmonary hypertension on prognosis and outcomes among patients with myeloproliferative neoplasms. Circ Cardiovasc Imaging. 2025;0:e017986.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"4255_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12185-022-03454-1","volume":"117","author":"O Leiva","year":"2023","unstructured":"Leiva O, Ren S, Neuberg D, Bhatt A, Jenkins A, Rosovsky R, et al. Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease. Int J Hematol. 2023;117(1):90\u20139.","journal-title":"Int J Hematol"},{"issue":"12","key":"4255_CR9","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.echo.2019.07.010","volume":"32","author":"J Kim","year":"2019","unstructured":"Kim J, Krichevsky S, Xie L, Palumbo MC, Rodriguez-Diego S, Yum B, et al. Incremental utility of right ventricular dysfunction in patients with myeloproliferative neoplasm-associated pulmonary hypertension. J Am Soc Echocardiogr. 2019;32(12):1574\u201385.","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"4255_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jamacardio.2022.1916","volume":"7","author":"YNV Reddy","year":"2022","unstructured":"Reddy YNV, Kaye DM, Handoko ML, van de Bovenkamp AA, Tedford RJ, Keck C, et al. Diagnosis of heart failure with preserved ejection fraction among patients with unexplained dyspnea. JAMA Cardiol. 2022;7(9):891\u20139.","journal-title":"JAMA Cardiol"},{"issue":"9","key":"4255_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","volume":"138","author":"YNV Reddy","year":"2018","unstructured":"Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018;138(9):861\u201370.","journal-title":"Circulation"},{"issue":"11","key":"4255_CR12","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/ajh\/hpz108","volume":"32","author":"D Sueta","year":"2019","unstructured":"Sueta D, Yamamoto E, Nishihara T, Tokitsu T, Fujisue K, Oike F, et al. H2FPEF score as a prognostic value in HFpEF patients. Am J Hypertens. 2019;32(11):1082\u201390.","journal-title":"Am J Hypertens"},{"issue":"1","key":"4255_CR13","first-page":"65","volume":"7","author":"S Suzuki","year":"2020","unstructured":"Suzuki S, Kaikita K, Yamamoto E, Sueta D, Yamamoto M, Ishii M, et al. H(2) FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors. ESC Heart Fail. 2020;7(1):65\u201374.","journal-title":"ESC Heart Fail"},{"issue":"4","key":"4255_CR14","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/ehf2.14773","volume":"11","author":"K Ishizu","year":"2024","unstructured":"Ishizu K, Shirai S, Isotani A, Hayashi M, Tabata H, Ohno N, et al. Long-term prognostic value of the H2FPEF score in patients undergoing transcatheter aortic valve implantation. ESC Heart Fail. 2024;11(4):2159\u201371.","journal-title":"ESC Heart Fail"},{"issue":"40","key":"4255_CR15","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","volume":"40","author":"B Pieske","year":"2019","unstructured":"Pieske B, Tschope C, de Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297\u2013317.","journal-title":"Eur Heart J"},{"issue":"6","key":"4255_CR16","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1002\/ehf2.14131","volume":"9","author":"D Hashemi","year":"2022","unstructured":"Hashemi D, Mende M, Trippel TD, Petutschnigg J, Hasenfuss G, Nolte K, et al. Evaluation of the HFA-PEFF score: results from the prospective DIAST-CHF cohort. ESC Heart Fail. 2022;9(6):4120\u20138.","journal-title":"ESC Heart Fail"},{"key":"4255_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.656536","volume":"8","author":"Y Sun","year":"2021","unstructured":"Sun Y, Si J, Li J, Dai M, King E, Zhang X, et al. Predictive value of HFA-PEFF score in patients with heart failure with preserved ejection fraction. Front Cardiovasc Med. 2021;8:656536.","journal-title":"Front Cardiovasc Med"},{"key":"4255_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.124.017986","author":"O Leiva","year":"2025","unstructured":"Leiva O, Soo S, Smilowitz NR, Reynolds H, Shah B, Bernard S, et al. Impact of echocardiographic probability of pulmonary hypertension on prognosis and outcomes among patients with myeloproliferative neoplasms. Circ Cardiovasc Imaging. 2025. https:\/\/doi.org\/10.1161\/CIRCIMAGING.124.017986.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"5","key":"4255_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1164\/rccm.202306-1001ED","volume":"208","author":"O Leiva","year":"2023","unstructured":"Leiva O, Garcia BD, Hobbs G. Pulmonary hypertension in myeloproliferative neoplasms: new insights and unexplored horizons. Am J Respir Crit Care Med. 2023;208(5):518\u201321.","journal-title":"Am J Respir Crit Care Med"},{"key":"4255_CR20","volume":"58","author":"X Wu","year":"2025","unstructured":"Wu X, Li J, Xu Z, Feng Y. Prognostic value of the HFA-PEFF and H(2) FPEF scores for clinical outcomes in patients with coronary artery disease and preserved ejection fraction. Int J Cardiol Heart Vasc. 2025;58:101655.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"5","key":"4255_CR21","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1182\/blood-2008-02-138230","volume":"112","author":"CS Tam","year":"2008","unstructured":"Tam CS, Nussenzveig RM, Popat U, Bueso-Ramos CE, Thomas DA, Cortes JA, et al. The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms. Blood. 2008;112(5):1628\u201337.","journal-title":"Blood"},{"key":"4255_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123551","author":"J Baumeister","year":"2021","unstructured":"Baumeister J, Chatain N, Sofias AM, Lammers T, Koschmieder S. Progression of myeloproliferative neoplasms (MPN): diagnostic and therapeutic perspectives. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10123551.","journal-title":"Cells"},{"key":"4255_CR23","doi-asserted-by":"crossref","unstructured":"Tefferi A, Guglielmelli P, Larson DR, Finke C, Wassie EA, Pieri L, et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood. 2014;124(16):2507\u201313; quiz 615.","DOI":"10.1182\/blood-2014-05-579136"},{"issue":"7853","key":"4255_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","volume":"592","author":"TP Fidler","year":"2021","unstructured":"Fidler TP, Xue C, Yalcinkaya M, Hardaway B, Abramowicz S, Xiao T, et al. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature. 2021;592(7853):296\u2013301.","journal-title":"Nature"},{"issue":"20","key":"4255_CR25","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1182\/blood.2024024187","volume":"144","author":"RL Zon","year":"2024","unstructured":"Zon RL, Sekar A, Clapham K, Oren O, Niroula A, Bick AG, et al. JAK2-mutant clonal hematopoiesis is associated with venous thromboembolism. Blood. 2024;144(20):2149\u201354.","journal-title":"Blood"},{"issue":"4","key":"4255_CR26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ajh.27216","volume":"99","author":"A Tefferi","year":"2024","unstructured":"Tefferi A, Vannucchi AM, Barbui T. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management. Am J Hematol. 2024;99(4):697\u2013718.","journal-title":"Am J Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04255-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04255-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04255-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:53:21Z","timestamp":1793282001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04255-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["4255"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04255-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no relevant conflict of interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}